USPTO published a patent application for an implantable spacer device with pressure-responsive delivery valves for controlled administration of medical fluids. The device comprises a plurality of delivery valves arranged on an outer surface, fluidically connected through an internal channel system. The valves are configured to open reversibly based on fluid pressure to deliver the medical fluid. CPC classifications include A61M 5/16881, A61F 2/484, and related medical device categories.\n\nThis is a patent application publication, not a regulatory requirement. Medical device manufacturers and researchers may review the technical approach for potential licensing considerations or to assess the patent landscape for spacer and drug delivery valve technologies. No compliance actions are required.